Clinical Trial

Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

Recruiting

Record status

This record was last updated November 6, 2024 (before its estimated April 30, 2025 completion). Its status may not reflect the trial's current state.

Summary

Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2023-06-13.

Status change: Not Yet Recruiting → Recruiting 2024-11-04

Trial Details

NCT Number	NCT05904340
Lead Sponsor	National Taipei University of Nursing and Health Sciences Collaborators: Changhua Christian Hospital
Conditions	Breast Neoplasms, Chemotherapy-induced Peripheral Neuropathy
Enrollment	86 participants
Start Date	2023-07-01
Primary Completion	2025-04-30 (estimated)
Study Completion	2025-04-30 (estimated)
Updated on ClinicalTrials.gov	2024-11-06